Pharmacoepidemiology in pregnancy
- PMID: 30797568
- DOI: 10.1016/j.therap.2018.11.014
Pharmacoepidemiology in pregnancy
Abstract
Taking a medication is usually a challenge for a pregnant woman as the beneficial drug effect on the mother has to be considered regarding its potential adverse effects, not only for her but also for her unborn child. As medication use is common in pregnant women, by chance or necessity, it gives the opportunity to evaluate the consequences of prenatal drug exposure in real life through pharmacoepidemiological studies. This paper provides an overview of data sources, study designs and data analysis methods that can be used for pregnancy medication safety studies. In the future, the implementation of responsive international networks may be the keystones of drug evaluation in pregnancy.
Keywords: Data sources; Long-term effects; Pharmacoepidemiology; Pregnancy.
Copyright © 2019 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
The importance of pharmacoepidemiology in pregnancy-implications for safety.Expert Opin Drug Saf. 2017 Oct;16(10):1181-1190. doi: 10.1080/14740338.2017.1363177. Epub 2017 Aug 10. Expert Opin Drug Saf. 2017. PMID: 28777918 Review.
-
How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):770-7. doi: 10.1002/pds.4000. Epub 2016 Mar 27. Pharmacoepidemiol Drug Saf. 2016. PMID: 27018245
-
Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP).J Popul Ther Clin Pharmacol. 2010 Fall;17(3):e336-40. Epub 2010 Oct 26. J Popul Ther Clin Pharmacol. 2010. PMID: 21041866
-
The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan.Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):854-9. doi: 10.1002/pds.4032. Epub 2016 May 25. Pharmacoepidemiol Drug Saf. 2016. PMID: 27222073 No abstract available.
-
Inclusion of pregnant and breastfeeding women in research - efforts and initiatives.Br J Clin Pharmacol. 2018 Feb;84(2):215-222. doi: 10.1111/bcp.13438. Epub 2017 Oct 22. Br J Clin Pharmacol. 2018. PMID: 28925019 Free PMC article. Review.
Cited by
-
Prevalence, trends, and characteristics of polypharmacy among US pregnant women aged 15 to 44 years: NHANES 1999 to 2016.Medicine (Baltimore). 2023 Jun 2;102(22):e33828. doi: 10.1097/MD.0000000000033828. Medicine (Baltimore). 2023. PMID: 37266635 Free PMC article.
-
Mothers of children with Down syndrome: a clinical and epidemiological study.J Community Genet. 2023 Apr;14(2):189-195. doi: 10.1007/s12687-022-00627-7. Epub 2022 Dec 23. J Community Genet. 2023. PMID: 36562914 Free PMC article.
-
Pragmatic and contextualized methods selection for safety assessment of infant systemic exposure through human milk: the Milk4baby decision tree approach - a contribution from the concePTION project.Front Pharmacol. 2025 Aug 5;16:1602018. doi: 10.3389/fphar.2025.1602018. eCollection 2025. Front Pharmacol. 2025. PMID: 40837399 Free PMC article.
-
The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives.Front Pharmacol. 2021 Jun 23;12:699062. doi: 10.3389/fphar.2021.699062. eCollection 2021. Front Pharmacol. 2021. PMID: 34248644 Free PMC article.
-
Chloroquine and hydroxychloroquine during pregnancy: What do we know?Therapie. 2020 Jul-Aug;75(4):384-385. doi: 10.1016/j.therap.2020.05.004. Epub 2020 May 11. Therapie. 2020. PMID: 32418732 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials